# OnCo record nct05786924 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05786924/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05786924", "NCT05786924" ;
  schema:name "Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies"@en ;
  schema:description "A phase 1/2 trial of fOLFIRI (5-FU, leucovorin, irinotecan), cetuximab, panitumumab, gemcitabine and other drugs in colorectal cancer, run by Institut de Recherches Internationales Servier, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05786924/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05786924> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/>, <https://onco.cc/cancers/braf-v600e-colorectal/>, <https://onco.cc/cancers/kras-g12c-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/nab-paclitaxel/> .